Senseonics tops Q4 EPS estimates, misses sales expectations

This article was originally published here

Shares in Senseonics (NYSE:SENS) closed down -3% yesterday after the medical device maker met earnings expectations on Wall Street with its fourth quarter and full-year financial results, but narrowly missed sales estimates.

The Germantown, Md.-based company posted a net loss of -$16.3 million, or -12¢ per share, on sales of $2.9 million for the 3 months ended Dec. 31, for bottom-line loss of -64.6% compared with the same period last year.

Get the full story at our sister site, Drug Delivery Business News.

The post Senseonics tops Q4 EPS estimates, misses sales expectations appeared first on MassDevice.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply